Entasis Therapeutics Holdings Inc (ETTX)
US2936141033 - Common Stock
ChartMill assigns a Buy % Consensus number of 48% to ETTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is -6.85% below the current price.
ETTX was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about ETTX.
In the previous month the buy percentage consensus was at a similar level.
ETTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-06 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-03-08 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-03-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-10-20 | BMO Capital | Maintains | Outperform |
| 2021-10-19 | HC Wainwright & Co. | Maintains | Buy |